# The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-safety-tolerability-and-efficacy-of-once-daily-memantine-28-mg-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | George T. Grossberg,Facundo Manes,Ricardo Allegri,Luis Miguel Gutiérrez‐Robledo,Sergio Gloger,Lei Xie,Xiaohu Jia,Vojislav Pejović,M. L. Miller,James L. Perhach,Stephen M. Graham |
| Citations | 158 |
| DOI | 10.1007/s40263-013-0077-7 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s40263-013-0077-7.pdf |
| OpenAlex ID | https://openalex.org/W2009141508 |
| PMID | 23733403 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Sergio Gloger](https://scholariq.org/researchers/sergio-gloger/)

## Paper journal

- [CNS Drugs](https://scholariq.org/journals/cns-drugs/)

## Paper primary topic

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)

## Paper topics

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Cholinesterase and Neurodegenerative Diseases](https://scholariq.org/topics/cholinesterase-and-neurodegenerative-diseases/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.